The largest database of trusted experimental protocols

Omeprazole

Manufactured by Tokyo Chemical Industry
Sourced in Japan

Omeprazole is a proton pump inhibitor (PPI) used to reduce gastric acid production. It is a white to off-white crystalline powder that is soluble in water and alcohol. Omeprazole functions by inhibiting the H+/K+-ATPase enzyme system, which is responsible for the final step in gastric acid secretion.

Automatically generated - may contain errors

3 protocols using omeprazole

1

Amlodipine-Omeprazole Compatibility Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amlodipine besilate and omeprazole were obtained from Tokyo Chemical Industry Ltd., Oxford, UK. Amlodipine besilate (5 mg tablets) and omeprazole (20 mg gastro-resistant capsules) were obtained from Teva Ltd., Castleford, UK. Orablend® was obtained from Fagron, Newcastle upon Tyne, UK. Polyfuser B, the sodium bicarbonate solution (8.4%), was purchased from Fresenius Kabi, Chesire, UK. All other reagents for HPLC analysis, including potassium phosphate dibasic (≥99.0%) and methanol CHROMASOLV® (≥99.0%) were purchased from Sigma-Aldrich, Dorset, UK.
+ Open protocol
+ Expand
2

Synthesis and Quantification of Omeprazole Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Omeprazole was acquired from Tokyo chemical industry (Nihonbashi-honcho, Tokyo, Japan) while D3–Omeprazole was acquired from Cayman chemical (Ann Arbor, MI 48108, USA). Verapamil was obtained from Merck & Sigma–Aldrich (Yong-in, Gyeonggi-Do, Korea). Dimethyl sulfoxide (DMSO), formic acid, methanol (MeOH), HPLC grade acetonitrile (ACN) and HPLC grade distilled water (DW) were all obtained from Duksan reagents (Ansan, Gyeonggi-Do, Korea).
+ Open protocol
+ Expand
3

Omeprazole Treatment in LDO Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LDOs in DM with doxycycline at 2 µg/mL on day 5 for differentiation induction were treated with 100-µM omeprazole (Tokyo Chemical Industry Co., Japan) in DM for 48 hours. mRNA was extracted and subjected to qRT-PCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!